Cited by 1,251Cardiomyopathy and Myosin StudiesCardiovascular Effects of ExerciseCardiac electrophysiology and arrhythmias

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)

Open access

O'Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., McKenna, W. J., Omar, R. Z., Elliott, P. M., for the Hypertrophic Cardiomyopathy Outcomes Investigators·2014·European Heart Journal

DOI 10.1093/eurheartj/eht439

Open this paper in CoChat — free account Open PDF

Abstract

AIMS: Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death (SCD) in young adults. Current risk algorithms provide only a crude estimate of risk and fail to account for the different effect size of individual risk factors. The aim of this study was to develop and validate a new SCD risk prediction model that provides individualized risk estimates. METHODS AND RESULTS: The prognostic model was derived from a retrospective, multi-centre longitudinal cohort study. The model was developed from the entire data set using the Cox proportional hazards model and internally validated using bootstrapping. The cohort consisted of 3675 consecutive patients from six centres. During a follow-up period of 24 313 patient-years (median 5.7 years), 198 patients (5%) died suddenly or had an appropriate implantable cardioverter defibrillator (ICD) shock. Of eight pre-specified predictors, age, maximal left ventricular wall thickness, left atrial diameter, left ventricular outflow tract gradient, family history of SCD, non-sustained ventricular tachycardia, and unexplained syncope were associated with SCD/appropriate ICD shock at the 15% significance level. These predictors were included in the final model to estimate individual probabilities of SCD at 5 years. The calibration slope was 0.91 (95% CI: 0.74, 1.08), C-index was 0.70 (95% CI: 0.68, 0.72), and D-statistic was 1.07 (95% CI: 0.81, 1.32). For every 16 ICDs implanted in patients with ≥4% 5-year SCD risk, potentially 1 patient will be saved from SCD at 5 years. A second model with the data set split into independent development and validation cohorts had very similar estimates of coefficients and performance when externally validated. CONCLUSION: This is the first validated SCD risk prediction model for patients with HCM and provides accurate individualized estimates for the probability of SCD using readily collected clinical parameters.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/eurheartj/eht439

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Multiple imputation using chained equations: Issues and guidance for practice
White, I. R., Royston, P., & Wood, A. M. (2011) · Statistics in Medicine · doi:10.1002/sim.4067 · Cited by 9,792
Regression Modeling Strategies
Harrell, F. E. (2001) · Springer series in statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,270
Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating
Steyerberg, E. W. (2019) · Statistics for Biology and Health · doi:10.1007/978-3-030-16399-0 · Cited by 3,281
Partial residuals for the proportional hazards regression model
SCHOENFELD, D. (1982) · Biometrika · doi:10.1093/biomet/69.1.239 · Cited by 3,111
Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
Elliot, P. M., Andersson, B., Arbustini, E., Bilińska, Z. T., Cecchi, F., Charron, P., Dubourg, O., Kühl, U., Maisch, B., McKenna, W. J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm342 · Cited by 2,995
Self-citation
Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates
Peduzzi, P., Concato, J., Feinstein, A. R., & Holford, T. R. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00048-8 · Cited by 2,154
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,116
Prognosis and prognostic research: what, why, and how?
Moons, K. G. M., Royston, P., Vergouwe, Y., Grobbee, D. E., & Altman, D. G. (2009) · BMJ · doi:10.1136/bmj.b375 · Cited by 1,337
Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy
Maron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259

Show all 50 references

Research works printed but not linked: 1

2012, Circulation: Arrhythmia and Electrophysiology, 6, 443

Sorted by citations

Items 501–600 of 999

The natural history of hypertrophic cardiomyopathy in a large Mediterranean cohort
Parcharidou, D. G., Zegkos, T., Ntelios, D., Panagiotidis, T., Katranas, S., Siskos, A., Meditskou, S., Karvounis, H. I., & Efthimiadis, G. K. (2020) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000945 · Cited by 10
Risk scoring for time to end-stage knee osteoarthritis: data from the Osteoarthritis Initiative
Dunn, R., Greenhouse, J. B., James, D., Ohlssen, D. I., & Mesenbrink, P. G. (2020) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2019.12.013 · Cited by 10
Correlations between cardiac troponin I and nonsustained ventricular tachycardia in hypertrophic obstructive cardiomyopathy
Liu, L., Liu, S., Shen, L., Tu, B., Hu, Z., Hu, F., Zheng, L., Ding, L., Fan, X., & Yao, Y. (2020) · Clinical Cardiology · doi:10.1002/clc.23425 · Cited by 10
Examining the impact of inducible ischemia on myocardial fibrosis and exercise capacity in hypertrophic cardiomyopathy
Malahfji, M., Senapati, A., Debs, D., Angulo, C., Zhan, Y., Nagueh, S. F., & Shah, D. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-71394-z · Cited by 10
Clinical Characteristics and Contemporary Management of Patients With Cardiomyopathies in Japan ― Report From a National Registry of Clinical Personal Records ―
Enzan, N., Matsushima, S., Ide, T., Kaku, H., Tohyama, T., Funakoshi, K., Higo, T., & Tsutsui, H. (2021) · Circulation Reports · doi:10.1253/circrep.cr-21-0001 · Cited by 10
Sudden cardiac death risk in hypertrophic cardiomyopathy: comparison between echocardiography and magnetic resonance imaging
Śpiewak, M., Kłopotowski, M. M., Kowalik, E., Kubik, A., Ojrzyńska, N., Petryka, J., Michalak, E., Mazurkiewicz, Ł., Gawor, M., Kożuch, K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-86532-4 · Cited by 10
A novel cardiovascular magnetic resonance risk score for predicting mortality following surgical aortic valve replacement
Vassiliou, V. S., Pavlou, M., Malley, T. S., Halliday, B. P., Tsampasian, V., Raphael, C. E., Tse, G., Vieira, M. S., Auger, D., Everett, R. J., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-99788-7 · Cited by 11
Self-citation
Kommentar zu den Leitlinien 2022 der ESC zu ventrikulären Arrhythmien und Prävention des plötzlichen Herztodes
Eckardt, L., Könemann, H., Bosch, R., Deneke, T., Falk, V., Perings, C. A., Schulz‐Menger, J., & Meyer, C. G. (2023) · Die Kardiologie · doi:10.1007/s12181-022-00589-7 · Cited by 10
The role of imaging in the diagnosis and management of hypertrophic cardiomyopathy
Weissler‐Snir, A., Crean, A. M., & Rakowski, H. (2015) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2016.1113130 · Cited by 10
Rapid Device‐Detected Nonsustained Ventricular Tachycardia in the Risk Stratification of Hypertrophic Cardiomyopathy
VISWANATHAN, K., Suszko, A. M., Das, M., Jackson, N. M., Gollob, M. H., CAMERON, D. A., SPEARS, D. A., Woo, A., Rakowski, H., Khurana, M., et al. (2016) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12861 · Cited by 10
Non-surgical septal reduction therapy in hypertrophic cardiomyopathy
Cooper, R. M., & Stables, R. (2017) · Heart · doi:10.1136/heartjnl-2016-309952 · Cited by 10
Incremental Value of an Insertable Cardiac Monitor in Patients with Hypertrophic Cardiomyopathy with Low or Intermediate Risk for Sudden Cardiac Death
Sakhi, R., Huurman, R., Theuns, D. A. M. J., Schinkel, A. F. L., Assaf, A., Szili‐Törok, T., Roos‐Hesselink, J. W., Michels, M., & Yap, S. (2021) · Cardiology · doi:10.1159/000512656 · Cited by 10
Comentarios a la guía de práctica clínica de la ESC 2014 sobre el diagnóstico y manejo de la miocardiopatía hipertrófica. Una vision crítica desde la cardiología española
hipertrófica, G. D. T. D. L. S. P. L. G. D. L. E. 2. S. E. D. Y. M. D. L. M., hipertrófica, R. E. P. L. G. D. L. E. 2. S. E. D. Y. M. D. L. M., & Comité de Guías de la, S. E. C. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2014.11.005 · Cited by 9
A cost-effectiveness analysis of hypertrophic cardiomyopathy sudden cardiac death risk algorithms for implantable cardioverter defibrillator decision-making
Green, N., Chen, Y., O’Mahony, C., Elliot, P. M., Villa, R. B., Monserrat, L., Anastasakis, A., Biagini, E., Gimeno, J. R., Limongelli, G., et al. (2023) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcad050 · Cited by 9
Self-citation
Prediction of incident atrial fibrillation in hypertrophic cardiomyopathy
Losi, M. A., Monda, E., Lombardi, R., Lioncino, M., Canciello, G., Rubino, M., Todde, G., Caiazza, M., Borrelli, F., Fusco, A., et al. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.131575 · Cited by 9
Self-citation
TIP FAKÜLTESİ ÖĞRENCİLERİNİN TIBBİ YAPAY ZEKA HAZIR BULUNUŞLULUĞUNUN İNCELENMESİ
Gencer, K., & Gencer, G. (2024) · Kocatepe tıp dergisi. · doi:10.18229/kocatepetip.1295779 · Cited by 14
Diretriz sobre Diagnóstico e Tratamento da Cardiomiopatia Hipertrófica – 2024
Fernandes, F., Simões, M. V., Correia, E. D. B., Marcondes‐Braga, F. G., Coelho‐Filho, O. R., Mesquita, C. T., Mathias, W., Antunes, M. D. O., Arteaga-Fernández, E., Rochitte, C. E., et al. (2024) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20240415 · Cited by 31
The diagnosis and treatment of hypertrophic cardiomyopathy
Möbius-Winkler, M. N., Laufs, U., & Lenk, K. (2024) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2024.0196 · Cited by 10
Standard breath-hold versus free-breathing real-time cine cardiac MRI—a prospective randomized comparison in patients with known or suspected cardiac disease
Elshibly, M., Shergill, S., Parke, K. S., Budgeon, C. A., England, R., Grafton‐Clarke, C., Elshibly, F., Kellman, P., McCann, G. P., & Arnold, J. R. (2025) · European Heart Journal - Imaging Methods and Practice · doi:10.1093/ehjimp/qyaf042 · Cited by 9
Updates on inherited arrhythmia syndromes (Brugada syndrome, long QT syndrome, CPVT, ARVC)
Moore, B. M., Roston, T. M., Laksman, Z., & Krahn, A. D. (2025) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2025.06.002 · Cited by 9
Myosin-binding Protein C Compound Heterozygous Variant Effect on the Phenotypic Expression of Hypertrophic Cardiomyopathy
Rafael, J. F., Cruz, F. E. S., de Carvalho, A. C. C., Gottlieb, I., Cazelli, J. G., Siciliano, A. P. D. R. V., & Dias, G. M. (2017) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20170045 · Cited by 9
Myocardial early systolic lengthening predicts mid-term outcomes in patients with hypertrophic cardiomyopathy
Candan, Ö., Geçmen, Ç., Kahyaoğlu, M., Şimşek, Z., Çelık, M., & Kırma, C. (2021) · International journal of cardiac imaging · doi:10.1007/s10554-021-02484-w · Cited by 9
Art and science of risk stratification of sudden cardiac death in hypertrophic cardiomyopathy: Current state, unknowns, and future directions
Siontis, K. C., Ommen, S. R., & Geske, J. B. (2023) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2023.08.005 · Cited by 9
Unlocking the predictive potential of long non-coding RNAs: a machine learning approach for precise cancer patient prognosis
Mo, Y., Adu‐Amankwaah, J., Qin, W., Gao, T., Hou, X., Fan, M., Liao, X., Jia, L., Zhao, J., Yuan, J., et al. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2279748 · Cited by 7
Effect of beta-blockers and exercise restriction on the prevention of sudden cardiac death in pediatric hypertrophic cardiomyopathy
Ito, Y., Sakaguchi, H., Tsuda, E., & Kurosaki, K. (2023) · Journal of Cardiology · doi:10.1016/j.jjcc.2023.11.009 · Cited by 9
Relation Between Temperature Extremes and Symptom Exacerbation in Patients With Hypertrophic Cardiomyopathy
Bois, J. P., Adams, J. C., Kumar, G., Ommen, S. R., Nishimura, R. A., & Klarich, K. W. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.12.046 · Cited by 10
Causes of death and mortality in hypertrophic cardiomyopathy patients with implantable defibrillators in Sweden
Magnusson, P., Gadler, F., Liv, P., & Mörner, S. (2016) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000359 · Cited by 9
Calculated Risk for Sudden Cardiac Death in Patients with Apical Versus Nonobstructive Nonapical Hypertrophic Cardiomyopathy
Zadok, O. I. B., Hasdai, D., Witberg, G., Shapira, Y., Vaturi, M., & Monakier, D. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.07.014 · Cited by 9
Etiology-Discriminative Multimodal Imaging of Left Ventricular Hypertrophy and Synchrotron-Based Assessment of Microstructural Tissue Remodeling
Lončarić, F., García‐Canadilla, P., García‐Álvarez, A., Sanchís, L., Prat, S., Doltra, A., Quintana, E., Pereda, D., Dejea, H., Bonnin, A., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.670734 · Cited by 9
Data-driven point-of-care risk model in patients with acute myocardial infarction and cardiogenic shock
Helgestad, O. K. L., Povlsen, A. L., Josiassen, J., Möller, S., Hassager, C., Jensen, L. O., Holmvang, L., Schmidt, H., Møller, J. E., & Ravn, H. B. (2021) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuab045 · Cited by 9
Perspective on precision medicine in paediatric heart failure
Fridman, M. D., & Mital, S. R. (2017) · Clinical Science · doi:10.1042/cs20160414 · Cited by 9
Left ventricular twist in hypertrophic cardiomyopathy
Candan, Ö., Geçmen, Ç., Kalaycı, A., Bayam, E. M., Güner, A., Gündüz, S., Çerşit, S., & Ozkan, M. (2017) · Herz · doi:10.1007/s00059-017-4633-7 · Cited by 9
Clinical presentations of hypertrophic cardiomyopathy and implications for therapy
Díez‐López, C., & Salazar‐Mendiguchía, J. (2018) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2018.19 · Cited by 9
Evaluating and Reducing the Risk of Sudden Death in Hypertrophic Cardiomyopathy
Udelson, J. E. (2019) · Circulation · doi:10.1161/circulationaha.118.038436 · Cited by 9
Hypertrophic cardiomyopathy in patients with a normal electrocardiogram: A view from the east side of the Atlantic Ocean
Dores, H., Toste, A., & Cardim, N. M. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.131260 · Cited by 8
Atrial remodelling and dysfunction in hypertrophic cardiomyopathy: prognostic role and therapeutic target
Piazzai, C., Petrone, A., Stefanini, A., D’Ascenzi, F., Olivotto, I., & Cameli, M. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1620313 · Cited by 8
Cardiopulmonary exercise testing in hypertrophic cardiomyopathy: the role of reduced O2 pulse and chronotropic incompetence in myocardial adaptation
Willixhofer, R., Mapelli, M., Baracchini, N., Campana, N., Capovilla, T. M., Nava, A., Salvioni, E., Vignati, C., Rubbo, F. M., Magrì, D., et al. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf402 · Cited by 8
Pathophysiology and Therapeutic Needs in Nonobstructive Hypertrophic Cardiomyopathy
Desai, M. Y., Maurizi, N., Biagini, E., Charron, P., Fernandes, F., González-López, E., van Haelst, P. L., Haugaa, K. H., Kramer, C. M., Meder, B., et al. (2025) · JACC Heart Failure · doi:10.1016/j.jchf.2025.102658 · Cited by 8
Self-citation
Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic Cardiomyopathy
Vissing, C. R., Raja, A. A., Helms, A. S., Saberi, S., OWENS, A. T., Rossano, J. W., Abrams, D. J., Ingles, J., Gray, B. R., Lampert, R. J., et al. (2026) · Circulation · doi:10.1161/circulationaha.125.076036 · Cited by 8
Evolution and Transformation of Hypertrophic Cardiomyopathy From a High Risk to a Treatable Low Mortality Disease With Contemporary Clinical Research Strategies
Maron, B. J., Ommen, S. R., Nishimura, R. A., McKenna, W. J., Rakowski, H., Sherrid, M. V., Olivotto, I., Braunwald, E., & Maron, M. S. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.047462 · Cited by 9
Self-citation
Cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy: single center implant data extracted from the Swedish pacemaker and ICD registry
Valzania, C., Gadler, F., Boriani, G., Rapezzi, C., & Eriksson, M. J. (2020) · Scandinavian Cardiovascular Journal · doi:10.1080/14017431.2020.1727000 · Cited by 8
Self-citation
Relationship between Left Ventricular Outflow Tract Pressure Gradient and Hemoglobin in Patients with Hypertrophic Cardiomyopathy.
Lin, Y., Yu, L., Liu, F., Lin, X., Li, H., & Xu, X. (2020) · PubMed Central · doi:10.6515/acs.202007_36(4).20191206a · Cited by 8
Added value of systemic inflammation markers in predicting pulmonary infection in stroke patients
Lv, Z., Lv, W., Lei, W., & Ning, Z. (2021) · Medicine · doi:10.1097/md.0000000000028439 · Cited by 8
Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients
Wang, M., Peterson, D. R., Pagan, E., Bagnardi, V., Mazzanti, A., McNitt, S. A., Rich, D. Q., Seplaki, C. L., Kutyifa, V., Polonsky, B., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.988951 · Cited by 8
Effectiveness of 2014 ESC HCM-Risk-SCD score in prediction of appropriate implantable-cardioverter-defibrillator shocks
Buongiorno, A. L., Blandino, A., Bianchi, F., Masi, A. S., Pierri, A., Mabritto, B. M. T., Bongioanni, S., Grossi, S., Mascia, G., Porto, I., et al. (2023) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001458 · Cited by 8
Prediction of Sudden Cardiac Death: Looking Beyond Ejection Fraction
Chatterjee, N. A. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-01871-0 · Cited by 8
Exercise recommendations for patients with hypertrophic cardiomyopathy
Bryde, R. E., Martinez, M. W., & Emery, M. S. (2023) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2023.05.004 · Cited by 8
T-Wave Analysis on the 24 h Holter ECG Monitoring as a Predictive Assessment of Major Adverse Cardiovascular Events in Patients with Myocardial Infarction: A Literature Review and Future Perspectives
Duca, Ș.-T., Roca, M., Costache, A. D., Chetran, A., Afrăsânie, I., Miftode, R.-Ş., Tudorancea, I., Matei, I. T., Ciorap, R., Mitu, O., et al. (2023) · Life · doi:10.3390/life13051155 · Cited by 8
Sudden cardiac death in childhood RASopathy-associated hypertrophic cardiomyopathy: Validation of the HCM risk-kids model and predictors of events
Boleti, O., Roussos, S., Norrish, G., Field, E., Oates, S., Tollit, J., Nepali, G., Bhole, V., Uzun, O., Daubeney, P. E. F., et al. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.131405 · Cited by 8
Differentiating Cardiac Troponin Levels During Cardiac Myosin Inhibition or Cardiac Myosin Activation Treatments: Drug Effect or the Canary in the Coal Mine?
Lee, M. M. Y., & Masri, A. (2023) · Current Heart Failure Reports · doi:10.1007/s11897-023-00620-2 · Cited by 8
Interventions in Hypertrophic Obstructive Cardiomyopathy
Ding, W. Y., Meah, M. N., Stables, R., & Cooper, R. M. (2023) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2023.12.001 · Cited by 8
Machine learning-based detection of sleep-disordered breathing in hypertrophic cardiomyopathy
Akita, K., Kageyama, S., Suzuki, S., Ohno, K., Kamakura, M., Nawada, R., Takanaka, C., Wakabayashi, Y., Kanda, T., Tawarahara, K., et al. (2024) · Heart · doi:10.1136/heartjnl-2023-323856 · Cited by 8
Risk profiles for ventricular arrhythmias in hypertrophic cardiomyopathy through clustering analysis including left ventricular strain.
Wazzan, A. A., Taconné, M., Rolle, V. L., Forså, M. I., Haugaa, K. H., Galli, E., Hernandez, A. I., Edvardsen, T., & Donal, E. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132167 · Cited by 8
ESC-Leitlinie 2014 zur Diagnose und zum Management der hypertrophischen Kardiomyopathie
Maisch, B., & Mahrholdt, H. (2014) · Herz · doi:10.1007/s00059-014-4177-z · Cited by 8
The Role of Genetic Testing in the Identification of Young Athletes with Inherited Primitive Cardiac Disorders at Risk of Exercise Sudden Death
Tiziano, F. D., Palmieri, V., Genuardi, M., & Zeppilli, P. (2016) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2016.00028 · Cited by 8
Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
Sánchez, D. J., & Lozano, I. F. (2018) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2018.31 · Cited by 9
Epidemiology of Heart Failure
Dahlström, U. (2019) · Cardiovascular medicine · doi:10.1007/978-3-319-98184-0_1 · Cited by 8
Differences in the extent of fibrosis in obstructive and nonobstructive hypertrophic cardiomyopathy
Avegliano, G. P., Politi, M. T., Costabel, J. P., Kuschnir, P., Trivi, M., & Ronderos, R. (2019) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000800 · Cited by 8
Additive prognostic significance of ejection fraction for ESC risk model in hypertrophic cardiomyopathy patients
Hen, Y., Iguchi, N., Kanisawa, M., Takada, K., Machida, H., Takara, A., Teraoka, K., Takamisawa, I., Takayama, M., & Yoshikawa, T. (2019) · Heart and Vessels · doi:10.1007/s00380-019-01496-w · Cited by 8
3D speckle tracking echocardiographic strain pattern in Hypertrophic Cardiomyopathy and its relation with Sudden Cardiac Death risk markers
Rakesh, K. B., Rajesh, G. N., & Vellani, H. (2020) · Indian Heart Journal · doi:10.1016/j.ihj.2020.11.144 · Cited by 8
Conversion of left atrial volume to diameter for automated estimation of sudden cardiac death risk in hypertrophic cardiomyopathy
Bhopalwala, H. M., Dewaswala, N., Liu, S., Scott, C. G., Welper, J. M., Akinnusotu, O., Bos, J. M., Ommen, S. R., Ackerman, M. J., Pellikka, P. A., et al. (2020) · Echocardiography · doi:10.1111/echo.14943 · Cited by 8
BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants—design and status
Jansen, M., Christiaans, I., van der Crabben, S. N., Michels, M., Huurman, R., Hoedemaekers, Y. M., Dooijes, D., Jongbloed, J. D. H., Boven, L. G., Deprez, R. H. L., et al. (2021) · Netherlands Heart Journal · doi:10.1007/s12471-021-01539-w · Cited by 8
Predicting Sudden Cardiac Death in Genetic Heart Disease
Cadrin‐Tourigny, J., & Tadros, R. (2022) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2022.01.025 · Cited by 8
Development and validation of a nomogram to predict the risk of death within 1 year in patients with non-ischemic dilated cardiomyopathy: a retrospective cohort study
Huang, Y., Wang, H., Wen, J., Yang, Z., & Gui, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-12249-7 · Cited by 8
Eurasian association of cardiology (EAC) guidelines for the prevention and treatment of ventricular heart rhythm disorders and prevention of sudden cardiac death (2022)
Sp, G., Kostyukevich, M. V., Laiovich, L. I., Mironov, N. Y., Миронова, Н. А., Utsumueva, M. D., Khusyainova, D. R., Шлевков, Н. Б., Bazarov, B. C., Азизов, В. А., et al. (2022) · Eurasian heart journal · doi:10.38109/2225-1685-2022-4-6-67 · Cited by 10
Multimodality Imaging in Sarcomeric Hypertrophic Cardiomyopathy: Get It Right…on Time
Galluzzo, A., Fiorelli, F., Rossi, V. A., Monzo, L., Montrasio, G., Camilli, M., Hálasz, G., Uccello, G., Mollace, R., & Beltrami, M. (2023) · Life · doi:10.3390/life13010171 · Cited by 8
Relationship between myocardial bridging and fatal ventricular arrhythmias in patients with hypertrophic cardiomyopathy: the HCM-MB study
Güner, A., Atmaca, S., Balaban, İ., Türkmen, I., Çeneli, D., Türkvatan, A., Öner, E., Sürgit, Ö., Güler, A., Uzun, F., et al. (2023) · Herz · doi:10.1007/s00059-023-05171-9 · Cited by 8
Validation of the ARIC prediction model for sudden cardiac death in the European population: The ESCAPE-NET project
Welten, S. J. G. C., Remmelzwaal, S., Blom, M. T., van der Heijden, A. A. W. A., Nijpels, G., Tan, H. L., van Valkengoed, I. G. M., Empana, J. P., Jouven, X., Ågesen, F. N., et al. (2023) · American Heart Journal · doi:10.1016/j.ahj.2023.03.018 · Cited by 8
Risk stratification in pediatric hypertrophic cardiomyopathy: Insights for bridging the evidence gap?
Nakano, S. J., & Menon, S. C. (2018) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2018.03.001 · Cited by 8
A Demonstration of Machine Learning in Detecting Frequency Following Responses in American Neonates
Hart, B. N., & Jeng, F.-C. (2020) · Perceptual and Motor Skills · doi:10.1177/0031512520960390 · Cited by 8
Role of imaging in evaluation of sudden cardiac death risk in hypertrophic cardiomyopathy
Geske, J. B., & Ommen, S. R. (2015) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000202 · Cited by 8
Hypertrophic cardiomyopathy: Past, present… and future
Bonow, R. O. (2014) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.10.012 · Cited by 8
The hypertrophic cardiomyopathy paradox: better with age
Geske, J. B., & Gersh, B. J. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy889 · Cited by 8
Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy
Pan, J. A. (2024) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2023.11.013 · Cited by 8
Contemporary review on pediatric hypertrophic cardiomyopathy: insights into detection and management
Shafqat, A., Shaik, A., Koritala, S., Mushtaq, A. H., Sabbah, B. N., Elshaer, A. N., & Baqal, O. J. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1277041 · Cited by 7
Incremental prognostic value of left atrial strain in apical hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study
Tang, Y., Ma, X., Wang, J., Yang, S., Dong, Z., Chen, X., Zhao, K., Wei, Z., Xu, J., Song, Y., et al. (2024) · European Radiology · doi:10.1007/s00330-024-11058-y · Cited by 7
Circulating microRNA as promising biomarkers in hypertrophic cardiomyopathy: can advanced cardiac magnetic resonance unlock new insights in research?
Сергеевна, Ч. О., & Mershina, E. A. (2024) · Experimental Biology and Medicine · doi:10.3389/ebm.2024.10334 · Cited by 9
Static Versus Dynamic Risk of Sudden Cardiac Death: Implications for Improvement of Prediction and Prevention
Pope, M. K., & Chugh, S. S. (2025) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.16654 · Cited by 7
Arrhythmias and Sudden Death: What is New in Hypertrophic Cardiomyopathy?
Rajan, D., Zörner, C. R., Hansen, M. L., & Tfelt‐Hansen, J. (2025) · Cardiac failure review · doi:10.15420/cfr.2024.38 · Cited by 10
Incremental prognostic value of epicardial adipose tissue volume and thickness assessed by cardiac MRI in hypertrophic cardiomyopathy
Song, Y., Hu, M., Ren, H., Fang, Q., Zheng, T., Feng, Z., Wang, X., Xu, L., & Gong, L. (2025) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeaf305 · Cited by 7
The Indices of Cardiovascular Magnetic Resonance Derived Atrial Dynamics May Improve the Contemporary Risk Stratification Algorithms in Children with Hypertrophic Cardiomyopathy
Ziółkowska, L., Mazurkiewicz, Ł., Petryka, J., Kowalczyk, M., Boruc, A., Bieganowska, K. D., Ciara, E., Piekutowska‐Abramczuk, D., Śpiewak, M., Miśko, J., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040650 · Cited by 7
The Echocardiographic Parameters of Systolic Function Are Associated with Specific Metabolomic Fingerprints in Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy
Deidda, M., Noto, A., Pasqualucci, D., Fattuoni, C., Barberini, L., Piras, C., Bassareo, P. P., Porcu, M., Mercuro, G., & Dessalvi, C. C. (2021) · Metabolites · doi:10.3390/metabo11110787 · Cited by 7
Protein Biomarkers of Adverse Clinical Features and Events in Sarcomeric Hypertrophic Cardiomyopathy
Tahir, U. A., Kolm, P., Kwong, R. Y. K., Desai, M. Y., Dolman, S. F., Deng, S., Appelbaum, E. A., Desvigne-Nickens, P. M., Dimarco, J., Tiwari, G., et al. (2024) · Circulation Heart Failure · doi:10.1161/circheartfailure.124.011707 · Cited by 7
Sudden cardiac death in inherited cardiomyopathy
Collis, R., & Elliot, P. M. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.04.006 · Cited by 7
Influence of functional polymorphism in MIF promoter on sudden cardiac death in Chinese populations
Yin, Z., Zhang, Q., Zhou, W., Wang, S., Wang, C., He, Y., Li, L., & Gao, Y. (2017) · Forensic Sciences Research · doi:10.1080/20961790.2017.1327744 · Cited by 7
Sleep Disordered Breathing in Hypertrophic Cardiomyopathy—Current State and Future Directions
Venkataraman, S., Karim, S., Rajendran, A., Chahal, C. A. A., & Somers, V. K. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9040901 · Cited by 8
Artificial Intelligence Applications to Improve Risk Prediction Tools in Electrophysiology
Kowlgi, G. N., Ezzeddine, F. M., & Kapa, S. (2020) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-020-00649-1 · Cited by 6
Preoperative echocardiography as a prognostic tool for liver transplant in patients with hypertrophic cardiomyopathy
Pai, S., Chadha, R., Logvinov, I. I., Brigham, T., Watt, K. D. S., Li, Z., Palmer, W. C., Blackshear, J. L., & Aniskevich, S. (2021) · Clinical Transplantation · doi:10.1111/ctr.14538 · Cited by 7
Genotype-Phenotype Correlation in Hypertrophic Cardiomyopathy: New Variant p.Arg652Lys in MYH7
Antoniutti, G., Caimi-Martínez, F., Álvarez-Rubio, J., Morlanes-Gracia, P., Llinares, J. P., Rodríguez-Picón, B., Fortuny-Frau, E., Torres‐Juan, L., Heine‐Suñer, D., & Ripoll‐Vera, T. (2022) · Genes · doi:10.3390/genes13020320 · Cited by 7
Anatomical-MRI Correlations in Adults and Children with Hypertrophic Cardiomyopathy
Roşu, R., Lupsor, A., Necula, A., Cismaru, G. L., Cainap, S. S., Iacob, D., Lazea, C., Cismaru, C. A., Negru, A. G., Pop, D., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12020489 · Cited by 7
Left Atrial Dysfunction as Marker of Arrhythmic Events in Patients with Hypertrophic Cardiomyopathy
Candan, Ö., Geçmen, Ç., Kahyaoğlu, M., Çelık, M., Şimşek, Z., Dindaş, F., Doğduş, M., Zehi̇r, R., & Kırma, C. (2022) · The Anatolian Journal of Cardiology · doi:10.5152/anatoljcardiol.2022.1832 · Cited by 7
Automated Quantification of Abnormal QRS Peaks From High‐Resolution ECGs Predicts Late Ventricular Arrhythmias in Hypertrophic Cardiomyopathy: A 5‐Year Prospective Multicenter Study
Suszko, A. M., Chakraborty, P., Viswanathan, K., Barichello, S., Sapp, J. L., Talajic, M. R., Laksman, Z., Yee, R., Woo, A., SPEARS, D. A., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.026025 · Cited by 7
Global research trends of hypertrophic cardiomyopathy from 2000 to 2022: Insights from bibliometric analysis
Zheng, X., He, Z., Li, M., & Jia, Z. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1039098 · Cited by 7
The safety of sports in children with inherited arrhythmia substrates
Katyal, A., Li, C. O. Y., Franciosi, S., & Sanatani, S. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1151286 · Cited by 7
Hypertrophic Cardiomyopathy: A Cardiovascular Challenge Becoming a Contemporary Treatable Disease
Sakellaropoulos, S., & Steinberg, B. S. (2023) · Cardiology Research · doi:10.14740/cr1514 · Cited by 8
Association between left atrial myopathy and sarcomere mutation in patients with hypertrophic cardiomyopathy: insights into left atrial strain by MRI feature tracking
Wang, J., Ma, X., Zhao, K., Yang, S., Yang, K., Yu, S., Yin, G., Dong, Z., Song, Y., Cui, C., et al. (2023) · European Radiology · doi:10.1007/s00330-023-10128-x · Cited by 7
New Insights and Recommendations for Athletes With Hypertrophic Cardiomyopathy
McKinney, J., Isserow, M., Wong, J., Isserow, S., & Moulson, N. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.02.008 · Cited by 7
NOS1AP Polymorphisms Modify QTc Interval Duration But Not Cardiac Arrest Risk in Hypertrophic Cardiomyopathy
Earle, N. J., Ingles, J., Bagnall, R. D., Gray, B. R., Crawford, J., Smith, W., Shelling, A. N., Love, D. R., Semsarian, C., & Skinner, J. R. (2015) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12827 · Cited by 7
A Narrative Review for Anesthesiologists of the 2017 American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Dalia, A. A., Essandoh, M. K., Cronin, B., Hussain, N., Gerstein, N. S., & Schulman, P. M. (2019) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2019.01.004 · Cited by 7
The Clinical Utility and Enduring Versatility of Stress Echocardiography
Quah, J. X., Greaves, K., Thomas, L., & Stanton, T. (2019) · Heart Lung and Circulation · doi:10.1016/j.hlc.2019.02.188 · Cited by 7

Authors: O'Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., McKenna, W. J., Omar, R. Z., Elliott, P. M., & for the Hypertrophic Cardiomyopathy Outcomes Investigators
Affiliations: University College London (GB)
National and Kapodistrian University of Athens (GR)
University of Bologna (IT)
Hospital Universitario Virgen de la Arrixaca (ES)
University of Campania "Luigi Vanvitelli" (IT)
University College Hospital at Westmoreland Street (GB)
ORCID: Pavlou, M.
Monserrat, L.
Rapezzi, C.
Biagini, E.
Gimeno, J. R.
Limongelli, G.
McKenna, W. J.
Omar, R. Z.
Venue: European Heart Journal
Publisher: Oxford University Press (OUP)
Published: 2013-10-14
Volume: 35
Issue: 30
Pages: 2010-2020
ISSN: 0195-668X (ISSN-L)
1522-9645
DOI: 10.1093/eurheartj/eht439
OpenAlex: W2119361626
Cited by: 1,251
References: 50
Citations by year: 2026: 107 · 2025: 124 · 2024: 115 · 2023: 120 · 2022: 99 · 2021: 125 · 2020: 116 · 2019: 87 · 2018: 81 · 2017: 100 · 2016: 67 · 2015: 76 · 2014: 31 · 2013: 2
FWCI: 39.92
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: European Heart Journal (publishedVersion)
PubMed (publishedVersion)
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
UCL Discovery (University College London) (submittedVersion)
Hispana (submittedVersion)
Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
RUNA. Repositorio Institucional del Sergas (Servicio Gallego de Salud (SERGAS)) (submittedVersion, other-oa)
Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
INFM-OAR (INFN Catania) (submittedVersion, other-oa)
Funders: National Institute for Health and Care Research (NF-SI-0509-10230)
Università di Bologna
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords: hypertrophic cardiomyopathy, sudden cardiac death, risk prediction model, individualized risk estimation, implantable cardioverter-defibrillator, left ventricular wall thickness, left ventricular outflow tract gradient, family history of sudden cardiac death, non-sustained ventricular tachycardia, unexplained syncope, left atrial diameter, model validation
MeSH terms: Adult, Cardiomyopathy, Hypertrophic, Female, Humans, Male, Middle Aged, Prognosis, Retrospective Studies, Reproducibility of Results, Proportional Hazards Models, Death, Sudden, Cardiac, Sample Size, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks